Canada Patent Protections In Spotlight As PhRMA Seeks Addition To “Priority Watch List”

The drug industry sees a not-so-friendly neighbor to the North and wants help from the Office of the U.S. Trade Representative to get Canada to change its “promise utility doctrine.”